Breast cancer is currently one of the most common malignant tumors in women worldwide. Triple-negative breast cancer (TNBC) is a special type of breast cancer which is highly aggressive, and associated with poor prognosis and lack of systemic treatment options at present. Here, the authors address the latest progress in treatment of this condition.